The novel Mechanical Ventilator Milano for the COVID-19 pandemic.
Journal
Physics of fluids (Woodbury, N.Y. : 1994)
ISSN: 1070-6631
Titre abrégé: Phys Fluids (1994)
Pays: United States
ID NLM: 101286829
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
16
01
2021
accepted:
14
02
2021
entrez:
26
4
2021
pubmed:
27
4
2021
medline:
27
4
2021
Statut:
ppublish
Résumé
This paper presents the Mechanical Ventilator Milano (MVM), a novel intensive therapy mechanical ventilator designed for rapid, large-scale, low-cost production for the COVID-19 pandemic. Free of moving mechanical parts and requiring only a source of compressed oxygen and medical air to operate, the MVM is designed to support the long-term invasive ventilation often required for COVID-19 patients and operates in pressure-regulated ventilation modes, which minimize the risk of furthering lung trauma. The MVM was extensively tested against ISO standards in the laboratory using a breathing simulator, with good agreement between input and measured breathing parameters and performing correctly in response to fault conditions and stability tests. The MVM has obtained Emergency Use Authorization by U.S. Food and Drug Administration (FDA) for use in healthcare settings during the COVID-19 pandemic and Health Canada Medical Device Authorization for Importation or Sale, under Interim Order for Use in Relation to COVID-19. Following these certifications, mass production is ongoing and distribution is under way in several countries. The MVM was designed, tested, prepared for certification, and mass produced in the space of a few months by a unique collaboration of respiratory healthcare professionals and experimental physicists, working with industrial partners, and is an excellent ventilator candidate for this pandemic anywhere in the world.
Identifiants
pubmed: 33897243
doi: 10.1063/5.0044445
pii: 5.0044445
pmc: PMC8060010
doi:
Types de publication
Journal Article
Langues
eng
Pagination
037122Informations de copyright
© 2021 Author(s).
Références
EBioMedicine. 2020 Nov;61:103104
pubmed: 33158808
Phys Fluids (1994). 2020 Jul 1;32(7):072105
pubmed: 35002196
Intensive Care Med. 2020 Dec;46(12):2200-2211
pubmed: 32728965
Anaesthesia. 1961 Jul;16:317-23
pubmed: 13766194
J Cardiothorac Vasc Anesth. 2012 Jun;26(3):486-506
pubmed: 21601477
Phys Fluids (1994). 2020 May 1;32(5):053310
pubmed: 32574229
Cochrane Database Syst Rev. 2015 Jan 14;1:CD008807
pubmed: 25586462
Lancet Respir Med. 2021 Feb;9(2):139-148
pubmed: 33169671
Crit Care. 2016 Aug 20;20:263
pubmed: 27542352
Mayo Clin Proc. 2017 Sep;92(9):1382-1400
pubmed: 28870355
Phys Fluids (1994). 2020 Sep 1;32(9):097102
pubmed: 32982136
JAMA. 2020 Jun 9;323(22):2329-2330
pubmed: 32329799
South Med J. 2018 Dec;111(12):746-753
pubmed: 30512128
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Crit Care. 2020 Aug 28;24(1):529
pubmed: 32859264
Intensive Care Med. 2005 Jun;31(6):776-84
pubmed: 15812622
Lancet. 1967 Aug 12;2(7511):319-23
pubmed: 4143721
Anaesthesia. 1995 Jan;50(1):64-71
pubmed: 7702149
JAMA. 2020 Apr 21;323(15):1499-1500
pubmed: 32159735
Chest. 1997 Oct;112(4):1102-6
pubmed: 9377923
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564
pubmed: 32348678